Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase 1 and Phase 2 Clinical Trials of Cancer Chemopreventive Agents
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
High Performance Computing Cluster for Bioimaging and Computational Biology
Exocytosis & Recycling in Rbl 2H3 Mucosal Mast Cells
New Relationship of Apoe to Neuronal Vulnerability in Ad
Scor in Pathobiology of Lung Development
Primary Rodent Production Center, Task A
Recently added grants:
State-dependent interaction of antiepileptic drugs with voltage-dependent sodium channels and differential regulation of excitatory and inhibitory central neurons
Mutant Mouse Resource and Research Center at UC Davis
The Resource of the MMRRC at UC Davis
Research Projects #1 and #2
Research Project #3
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN35159-7-0-1
Application #
7579651
Study Section
Project Start
2003-09-30
Project End
2008-09-29
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Phase 1 and Phase 2 Clinical Trials of Cancer Chemopreventive Agents
/ University of Texas MD Anderson Cancer Center
$1,877,000
NIH 2007
N01 CA
Phase I & II Clinical Trials of Chemopreventive Agents
Lippman, Scott M. /
$1,377,221
NIH 2007
N01 CA
Phase 1 and Phase 2 Clinical Trials of Cancer Chemopreventive Agents
/
Comments
Be the first to comment on this grant